Today’s Mistakes and Tomorrow’s Wisdom in Endoscopic Treatment and Follow-Up of Barrett’s Esophagus
- 18 March 2022
- journal article
- review article
- Published by S. Karger AG in Visceral Medicine
- Vol. 38 (3) , 189-195
Abstract
Background: Endoscopic therapy has replaced esophagectomy for the management of early Barrett’s neoplasia, allowing for the curative treatment of intramucosal adenocarcinoma, dysplastic Barrett’s esophagus (BE), and the prevention of metachronous recurrences. Summary: Endoscopic therapy relies on the resection of any visible lesion, suspicious of harboring cancer, followed by the eradication of the residual BE, potentially harboring dysplastic foci. Currently, endoscopic mucosal resection (EMR) using the multiband mucosectomy technique is the gold standard for the resection of visible lesions. Endoscopic submucosal dissection (ESD) is feasible with comparable complication rates to EMR, but longer procedural times. It is still limited to EMR failures or suspected submucosal adenocarcinoma. Eradication of residual BE mainly relies on radiofrequency ablation, with over 90% efficacy in expert centers. Despite initial complete eradication of BE, intestinal metaplasia and dysplasia recur in time, justifying prolonged endoscopic surveillance. Key Messages: The first step of the therapeutic endoscopy for BE is a careful diagnostic evaluation, searching for visible(s) lesion(s). EMR is the recommended resection technique for visible lesions. ESD has not demonstrated its superiority on EMR in routine practice. Endoscopic follow-up after Barrett’s eradication therapy is mandatory.Keywords
This publication has 41 references indexed in Scilit:
- Systematic review: the prevention of oesophageal stricture after endoscopic resectionAlimentary Pharmacology & Therapeutics, 2015
- Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)Gut, 2015
- Ablation of residual Barrett’s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study)Endoscopy, 2013
- Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- Endoscopic Mucosal Resection Results in Change of Histologic Diagnosis in Barrett’s Esophagus Patients with Visible and Flat Neoplasia: A Multicenter Cohort StudyDigestive Diseases and Sciences, 2013
- Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasiaGastrointestinal Endoscopy, 2011
- Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagusEndoscopy, 2011
- Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trialGut, 2011
- Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patientsGut, 2010
- Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagusGut, 2008